Published Medical Literature

Nivolumab Plus Relatlimab vs Nivolumab Alone in Advanced Melanoma

S6K2 Inhibition Shows Potential in Overcoming MAPK Inhibitor–Resistant NRAS-Mutated Melanoma

Immunotherapy for Cutaneous SCC: Are Antibiotics Linked to Negative Outcomes?

Immunologic Responses to Allogeneic Vaccine in Patients With Melanoma

Are Adult Survivors of Childhood Cancer at Increased Risk for Melanoma?

Is Tumor Upstaging Associated With Worse Prognosis in Invasive Melanoma?

Personalized Neoadjuvant Immunotherapy for Stage III Melanoma: Survival Insights

Wide vs Narrow Excision Margins in Melanoma Near Critical Structures

Is the Extent of DNA Methylation Prognostic in Melanoma?

Can Targeting Cancer-Associated Fibroblasts Enhance Immunotherapy Efficacy in Skin Cancers?

Teledermoscopy: A Safe and Accurate Way to Reduce Melanoma Health Disparities?

How Immunosuppression Impacts Merkel Cell Carcinoma Development in the United States

Chinese Study Identifies Prognostic Marker and Potential Therapeutic Target in Melanoma

Use of Neoadjuvant Atezolizumab in Advanced Squamous Cell Skin Cancer

Anti–PD-1 Therapy for Melanoma: A Closer Look at Immune-Related Adverse Events

Researchers Shed Light on Role of CD8-Positive T Cells in Progression of Melanoma

Nonmelanoma Skin Cancer: Improving Adherence to NCCN Guidelines for Preferred Treatment

Is Access to Tanning Bed Facilities Linked to Regional Melanoma Rates?

Older Individuals With Cutaneous Malignant Melanoma: 30-Year Trends

Accuracy of Skin Cancer Diagnosis: Focus on Lesion Type, Physician Experience, and Exam Method

Are Cryoablation and Immune Checkpoint Inhibition Synergistic in Metastatic Melanoma?

Use of Cemiplimab for Unresectable Squamous Cell Skin Cancer: Case Report

Safety Lead-in With First-Line Triplet Therapy for Advanced BRAF V600–Mutant Melanoma

Consensus on the Optimal Techniques for Mohs Micrographic Surgery in Melanoma

Germline Genetic Variation and Development of In Situ or Invasive Melanoma

Can Genetics Reveal Modifiable Risk Factors for Skin Cancer?

After PD-1 Inhibitors Fail: Is Ipilimumab an Option for Some With Metastatic Melanoma?

Study Reveals Potential Diagnostic Pitfall in Merkel Cell Carcinoma

Novel Tool May Predict Survival in Stage IV Melanoma After First-Line Immunotherapy

Advanced Melanoma: 10-Year Outcomes With Nivolumab and Ipilimumab Support Earlier Results

Neurologic Symptoms and Immunotherapy for Melanoma Brain Metastases: A View From New Zealand

Use of Cemiplimab in a 90-Year-Old Woman With Skin Cancer: Debunking Age ‘Myths’

Advanced Merkel Cell Carcinoma: Quality of Life With Immunotherapy

Immunotherapy for Melanoma: Can the Presence of Autoantibodies Predict Adverse Events?

Potential Biomarker Under Study in Patients With Rare Skin Disease and Squamous Cell Carcinoma

Basal Cell Carcinoma: Novel Clinical Algorithm May Help to Identify Those at High Risk

LAG-3 and PD-1 Inhibition: Working Together to Activate Immune Responses in Melanoma

Genomic Landscape of Squamous Cell Skin Cancer and Dermal Invasion

Hypoalbuminemia: An Independent Biomarker of Immunotherapy Response in Metastatic Melanoma?

Treating Metastatic Basal Cell Carcinoma With Cemiplimab: Focus on Quality of Life

Adjuvant Immunotherapy in Melanoma: Cell- and Tissue-Specific PD-L1 Expression May Predict Response

Recognizing Practice Patterns and Outcomes of a Rare Type of Skin Cancer

Standardized Guidelines for Retrospective Research in Cutaneous Squamous Cell Carcinoma

Immunotherapy for Merkel Cell Carcinoma: Are Tissue-Resident T Cells Drivers of Response?

Rurality, Race, and Lower Income: Researchers Find All Affect the Incidence of Skin Cancer

Merkel Cell Polyomavirus Serum Antibody Test May Facilitate Enhanced Risk Stratification

Incompletely Excised Basal Cell Carcinoma: Researchers Explore Next Best Steps

Are Patients Being Treated for Psoriasis at Risk for Skin Cancer?

Combination of BRAF and MEK Inhibition for BRAF V600/NRAS Q61 Wild-Type Melanoma

Can Circulating Biomarkers Predict Response to Immunotherapy in Metastatic Melanoma?

Vismodegib Plus Radiation Therapy for Locally Advanced, Unresectable Basal Cell Carcinoma

KEYNOTE-716 Trial Update: Adjuvant Pembrolizumab in Resected Stage IIB or IIC Melanoma

Do Race and Sex Play a Role in Nonmetastatic Melanoma?

Can New AI Tool Help to Distinguish Melanomas From Benign Skin Lesions? Swedish Researchers Say Yes

Diagnosing Non-Melanoma Skin Cancers: Novel Lipid Sampling Approach Under Study

Risk Prediction Calculator From Australia Under Study in Stage II Melanoma

Genomic Analysis Reveals Basal Cell Carcinoma Loci Across Ethnically Diverse Patient Population

Potential Link Between Smoking and Survival in Early-Stage Primary Melanoma

Second-Generation Vaccine for Melanoma Under Study: Did Men and Women Benefit Equally?

Age-Related Loss of Protein HAPLN1 May Contribute to Metastasis in Melanoma

Researchers Explore Combined Molecular Targeting for Preventing Skin Tumor Growth

Neoadjuvant Cemiplimab-rwlc and Surgery for Skin Cancer Subtype: Follow-up Trial Data

Novel Biomarker: Potential Link to Improved Therapy for Basal and Squamous Cell Carcinomas

Basal Cell Carcinoma: Using AI to Improve Tumor Excision and Patient Results

Three-Pronged Treatment Approach to Advanced Melanoma With BRAF V600 Mutation

Factors Influencing Non-Melanoma Skin Cancer: Trends in Sun Exposure and Comorbidities

Case Series: Features of Melanoma Among Black Patients in Dallas

Intermittent vs Continuous Dosing of Dabrafenib Plus Trametinib in Advanced Melanoma

Giant Advanced Basal Cell Carcinoma in the Axilla Region: Case Report

Cutaneous Squamous Cell Carcinoma: Link Between VEGFC Expression and Tumor Progression?

Basal Cell Carcinoma: Impact of Location of Metastasis on Survival Outcomes

Trends in UV Radiation Exposure and Risk of Non-Melanoma Skin Cancers

High-Frequency Ultrasound: Can It Differentiate Between Basal Cell Carcinoma Subtypes?

Early-Onset Merkel Cell Carcinoma: A New Member of the Family of Heritable Cancers?

Basal Cell Skin Cancer: Updated NCCN Guidelines Focus on Risk Stratification

Skin Cancer Prevention Measures Among Hispanic Individuals in Florida and Puerto Rico

Topical Patches for Non-Melanoma Skin Cancer: Collaboration May Conquer Challenges

Cutaneous Squamous Cell Carcinoma in Recipients of Solid Organ Transplants

Next-Generation, Small-Molecule BRAF Inhibitor Under Study in Skin Cancer

AI-Assisted Color Constancy: A Real-World Benefit in Skin Lesion Assessment?

Non-Melanoma Skin Cancer: Systemic Therapy Before Surgical Excision

Causes of Death in Patients With Cutaneous Squamous Cell Carcinoma: Risk Factors Tell the Story

FLASH Trial: Photodynamic Therapy Active in Early-Stage Cutaneous T-Cell Lymphoma

Skin Cancer on the Face: Case Study of Wide Excision Surgery With Frozen Section

A Profile of Basal Cell Carcinoma in Western Cape, South Africa

Secondary Mutations May Be Key to How Basal Cell Carcinomas Overcome Dormancy

Prevention of Skin Cancer Through Sun Exposure Education in Welsh Primary Schools

Are Military Populations at Increased Risk of Skin Malignancies?

New Findings Link Sonic Hedgehog Pathway Genes to Keratinocyte Cancers

Link Between Risk of Squamous Cell Skin Cancer and Severity of Actinic Keratosis?

Rare Case of Metatypical Basal Cell Carcinoma: Aggressive Nature Warrants Intensive Follow-Up

Diagnostic Utility of Immunohistochemistry for Cutaneous Basaloid Neoplasms

Prognostic Implications of Satellitosis or In-Transit Metastasis in Cutaneous Squamous Cell Carcinoma

Keratinocyte Cancer in Australia: Identifying Trends in Incidence and Risk

Are Solid Organ Transplant Recipients at Increased Risk for Skin Cancer?

MYBL2 and TK1: Biomarkers in Cutaneous Squamous Cell Carcinoma?

Does Exposure to the Kinase Inhibitor Ruxolitinib Increase the Risk of Skin Cancer?

Concordance Between Referral and Expert Diagnosis in Patients With Rare Skin Cancer

Zinc-Based Metal–Organic Frameworks: Potential Platform in Sun Protection?

Is Argon-Helium Cryoablation an Alternative for Older Patients With Unresectable Skin Cancer?

Diagnosis and Treatment of Locally Advanced Basal Cell Carcinoma: A Registry Study

Wounding Therapies and IGF-1/IGF-1R Signaling in Preventing Age-Associated Skin Cancer

Iridium-192 High-Dose–Rate Brachytherapy With Valencia Applicators in Treating Skin Cancer

Are Photoprotection Measures Needed for People of Color?

Digital Pathology Data Set of Skin Cancers Represents Countless Hours of Hand Annotations

Single-Center Experience With Sonidegib in Advanced Basal Cell Carcinoma

Is the Use of Tacrolimus and Pimecrolimus Associated With Risk of Skin Cancer?

Plesiotherapy for Skin Cancer: Customized Molds May Be Key to Success

Antimicrobial Peptides and Basal Cell Carcinoma

Overall Survival With Radiotherapy and Chemotherapy for Merkel Cell Carcinoma

Merkel Cell Carcinoma: Surgical Margin Positivity and Outcomes

Rare Case of Basal Cell Carcinoma Plus Sebaceous Carcinoma After Mohs Surgery

Basal Cell Carcinoma on the Nose Versus Other Sites of the Face: Appropriate Treatment Considerations

Case Report: Elderly Woman Experiences Spontaneous Regression of Merkel Cell Carcinoma

Which Patients With Basal Cell Carcinoma May Be Appropriate Candidates for Watchful Waiting?

Is Skin Cancer Risk Influenced by Vitamin D Serum Levels?

Combining CO₂ Laser, Diclofenac, and Imiquimod to Treat Inoperable Basal Cell Carcinoma

Is There a Possible Association Between Psoriasis and Cutaneous Squamous Cell Carcinoma?

Metastatic Basal Cell Carcinoma or Cutaneous Squamous Cell Carcinoma: Diagnostic Role of Genomic Tumor Sequencing

Interleukin 17A and Skin Cancer: A Potential Therapeutic Target?

Case Study: Potential Link Between JAK Inhibitor and Merkel Cell Carcinoma?

Molecular Profiling to Determine Genetic Variants in Young Patients With Basal Cell Carcinoma

Skin Cancer Following Solid Organ Transplantation and Transcribed HPV Infection

Avelumab in Electrochemotherapy-Resistant Merkel Cell Carcinoma: Case Report

Rare Case of Merkel Cell Carcinoma Associated With CLL

Measuring the Burden of Skin Cancers in the United States: From 1990 to 2019

Case Report: Avelumab Therapy for Metastatic Merkel Cell Carcinoma

Can Vismodegib Therapy Improve Visual Function for Patients With Basal Cell Carcinoma?

Intralesional Treatment of Skin Cancer in Double-Transplant Recipient: Case Report

Skin Cancer and Health-Related Quality of Life: Risk Factors and Patient Education

Expression of TRPM8 Protein in Non-Melanoma Skin Cancer

Skin Cancer Awareness Amid the Coronavirus Pandemic: Focus on Internet Searches

Could ALK Phosphorylation Be Linked to Outcomes in Merkel Cell Carcinoma?

Risk Factors by Skin Cancer Type Among Recipients of Organ Transplants

An Unusual Case of Merkel Cell Carcinoma Metastasis to the Kidneys

Locally Advanced Basal Cell Carcinoma: Use of Cemiplimab-rwlc After Hedgehog Inhibitor Therapy

Is Statin Exposure Associated With Squamous Cell Carcinoma Risk?

Is Paraoxonase-2 a Marker for Cutaneous Neoplasms?

Cutaneous Squamous Cell Carcinoma of the External Lip: 40-Year Trends

Treating Skin Cancers Around the Eye With Interstitial HDR Brachytherapy

Rate of Skin Cancer Diagnoses During COVID-19 Pandemic: Canadian Population Study

UVB-Induced Premalignant Skin Lesions: Novel Role of Dopamine D2 Receptors Identified

Unusual Case Presentation of an Ulcerative Variant of Merkel Cell Carcinoma

Developing a Digitized Deep Learning Model to Detect Basal Cell Carcinoma

Topical Ascorbic Acid Solution for Squamous Cell Carcinoma: Case Study

Case Report: Simultaneous Merkel Cell Carcinoma and Colorectal Cancer

Vismodegib Therapy and Xanthomatous Dermal Changes: Case Study in Basal Cell Carcinoma

Non-Melanoma Skin Cancer Incidence and Chronic Occupational Radiation Exposure

Are HCTZ-Containing Products Associated With Increased Risk of Non-Melanoma Skin Cancers?

Is Intralesional Fluorouracil Effective in Treatment of Cutaneous Squamous Cell Carcinoma?

Dermatoscopic Patterns in Non-Melanoma Skin Cancer

Clinical-Dermoscopic Profile of Infiltrative Basal Cell Carcinoma: A Potential Diagnostic Tool

Topical Tirbanibulin Under Study for the Treatment of Actinic Keratosis

Basosquamous Carcinoma: Shedding Light on a Rare Malignancy

Expression of G6PD: Prognostic Marker for Merkel Cell Carcinoma?

High–Dose-Rate Afterloading Brachytherapy for Basal and Squamous Cell Carcinomas

Intermittent Treatment With Vismodegib in Basal Cell Carcinoma: Pilot Study

Are Patients Treated With TNF-Alpha Antagonists for Inflammatory Bowel Disease at Risk for Skin Cancer?

Toxicity Associated With Concomitant Ruxolitinib and Avelumab in Merkel Cell Carcinoma

Potential Biomarkers of Cutaneous Squamous Cell Carcinoma From Actinic Keratosis

Merkel Cell Carcinoma and Interstitial Lung Disease: Case Report on Use of Pembrolizumab

Periauricular Basal Cell Carcinoma: Distribution and Surgical Treatment

Lifestyle Factors Possibly Associated With Non-Melanoma Skin Cancers

Superficial Brachytherapy for Skin Cancer Lesions on Lower Limbs: Case Report

Factors Affecting Excisional Margin Status of Skin Tumors

Rare Case of Basal Cell Carcinoma From Tattoo Ink

Presence of Immune Checkpoint Markers Identified in Cutaneous Angiosarcoma

Multimodal Therapeutic Approach to Aggressive Merkel Cell Carcinoma: Case Report

Immune Checkpoint Inhibition Among Patients With Dermatologic and Hematologic Cancers

Merkel Cell Carcinoma of the Sinonasal Mucosa: Case Report

Multisite Progression of Merkel Cell Carcinoma and Simultaneous Immune-Related Adverse Events

Evaluating Skin Cancer Risk Among Military Personnel

Iron Deficiency Anemia Associated With Basal Cell Carcinoma: Case Report

Novel Strategy for Treating Premalignant Skin Lesions Under Study

Response to Radiotherapy in Basal Cell Carcinoma: Comparison of Noninvasive Imaging Modalities

Case Study: Malignant Melanoma After Merkel Cell Carcinoma

Case Study: Basal Cell Carcinoma as a Nonhealing Lesion

Japanese Study Explores Risk Factors for Non-Melanoma Skin Cancer

Potential Biomarker Investigated for Merkel Cell Carcinoma

Are Chronic Venous Insufficiency and Basal Cell Carcinoma Connected?

Dermatoscopic Morphology: Predicting Nodular Non-Melanoma Versus Melanoma

Radiotherapy for Merkel Cell Carcinoma: Multidisciplinary Team Approach

Case of Basal Cell Carcinoma: Complications From Self-Treatment With Bloodroot Plant

Skin Cancer in Recipients of Liver and Kidney Transplants: Calcineurin Versus mTOR Inhibitors

Long-Term Outcomes in Surgically Managed Skin Cancer in Transplant Recipients

Biopsy Versus Reflectance Confocal Microscopy in Diagnosis of Basal Cell Carcinoma

Merkel Cell Carcinoma: Do Women Have Better Outcomes Than Men?

Cisplatin Electrochemotherapy for Small Non‐Melanoma Skin Lesions

Antimalaria Drug May Inhibit Virus-Positive Merkel Cell Carcinoma Growth

Multidisciplinary Approaches to Managing Merkel Cell Carcinoma

Skin Cancer Prevention: ASCO Issues Policy Statement

COVID-19 and Non-Melanoma Skin Cancer: Revisiting Hypofractionated Radiotherapy

Multiple Aggregated, Yellow-White Globules: Indicator of Basal Cell Carcinoma?

Non-Melanoma Skin Cancer and COVID-19: Modifications to Current Radiotherapy

Genetic Features of Virus-Positive Versus Virus-Negative Merkel Cell Carcinoma

Genetic Link Between Inflammatory Bowel Disease and Skin Cancer?

International Researchers Reveal Clues to Aggressive Skin Cancers

Finnish Researchers Find Unexpected Features of Recurrent and Metastatic Skin Cancers

Mohs Micrographic Surgery for Facial Skin Cancers: Do Patients Have Realistic Expectations?

Nivolumab Prior to Surgery in Patients With Merkel Cell Carcinoma

Could Non-Melanoma Skin Cancer Be Linked to Exfoliation Glaucoma?

Is Parkinson’s Disease Associated With Development of Skin Cancer?

miR-375 in Merkel Cell Carcinoma: An Intracellular Oncogene?

9-Valent HPV Vaccine in Managing Squamous Cell Carcinoma: Case Report

Early-Onset Basal Cell Carcinoma and Cosmetic Tattoos

Role of Autophagy-Related Gene 7 in Non-Melanoma Skin Cancer

Identifying Squamous Cell Carcinoma With Gold Nanoparticle Technology

Quantitative Proteomics Analysis Yields Insights in Merkel Cell Carcinoma

Potential Biomarker of Response to Vismodegib in Basal Cell Carcinoma

Update on Laser Therapies for Basal Cell Carcinoma

Researchers Identify New RNA Molecule in Growth of Squamous Cell Carcinoma

Pilot Study to Investigate Same-Day Diagnosis and Treatment of Basal Cell Carcinomas

Characterizing Bioenergetics of Basal Cell and Squamous Cell Carcinomas

Use of Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma

Evaluating Risk of Basal Cell Carcinoma Linked to Solar Ultraviolet Exposure

Risk of Internal Malignancies in Patients With Non-Melanoma Skin Cancer

Potential Link Between Psoriasis and Risk of Non-Melanoma Skin Cancer

Detecting Skin Cancer Using a Neural Network Algorithm

Patient Preference for Prevention of Non-Melanoma Skin Cancer After Organ Transplantation

ASTRO Clinical Practice Guideline for Radiation Therapy for Basal Cell and Squamous Cell Skin Cancers

Pilot Study Explores Potential Therapeutic Target for Merkel Cell Carcinoma

Alternative Reconstruction Option for Cutaneous Malignancy

Voriconazole and Development of Squamous Cell Carcinoma: Potential Mechanism Identified

Potential Link Between Kidney Disease and Increased Risk for Cutaneous Squamous Cell Carcinoma

Indoor Tanning: Increased Risk for Cutaneous Squamous Cell Carcinoma?

Do Individuals With Psoriasis Have an Increased Risk of Keratinocyte Cancers?

Cancer-Testis Antigens: Immunotherapy Targets for Merkel Cell Carcinoma?

Pembrolizumab for Xeroderma Pigmentosum and Advanced Squamous Cell Carcinoma: A Case Study

Comparison of Cosmesis With Four Treatments for Basal and Squamous Cell Carcinomas

Treatment of Basal Cell Carcinoma With Topical Itraconazole

‘Man With Machine’ Approach to Diagnosing Skin Cancer Lesions

Risk of Non-Melanoma Skin Cancer in Patients With Rare Genodermatosis

Grading of Non-Melanoma Skin Cancers: Mohs Micrographic Surgery vs. Initial Biopsy

Long-Term Outcomes With Mohs Surgery for Cutaneous Squamous Cell Carcinoma

Pembrolizumab Therapy for Inoperable Case of Squamous Cell Carcinoma

Does a Family History of Melanoma Increase the Risk of Keratinocyte Cancers?

Risk Factors for Non-Melanoma Skin Cancers in Recipients of Kidney Transplant

Case Study: Rare Keratoacanthoma and Presence of HPV39

Patterns of Major Surgery for Cutaneous Squamous Cell Carcinoma

Use of Avelumab in Merkel Cell Carcinoma: Linking Early Response With Overall Survival

Meta-analysis of Treatment of Skin Cancers With PD-1/PD-L1 Inhibitors

Quality of Life With Vismodegib Treatment of Non-Melanoma Skin Cancers

Standardized Total Body Skin Exam: Improved Accuracy and Efficiency?

Physicians Versus Machine-Learning Algorithms in Classifying Pigmented Skin Lesions

Factors Affecting Survival for Patients with Advanced Cutaneous Squamous Cell Carcinoma

Does PD-1 Expression Differ by Histology in Cutaneous Squamous Cell Carcinoma?

Treatment Patterns for Canadian Patients With Head and Neck Squamous Cell Carcinoma

Multikinase Inhibitor Shows Activity in Aggressive Subtype of Squamous Cell Carcinoma

Predicting Response to Immunotherapy in Squamous Cell Carcinoma

Link Between Skin Cancer Diagnosis and Health-Care Screening Practices

Molecular Role of Complement C3a in Cutaneous Squamous Cell Cancer

Does Squamous Cell Carcinoma Risk Change With Immunosuppression?

Extremity Nevus Count and Risk of Skin Cancers

Association of Indoor Tanning and Skin Cancer in Canada

Is There an Association Between Skin Cancer and Erectile Dysfunction Medications?

Keratinocyte Carcinoma: Update on Treatment and Prevention

Intermittent Vismodegib Regimen for Locally Advanced Basal Cell Carcinoma

Use of Pembrolizumab in First-Line Treatment of Merkel Cell Carcinoma

Comparing Staging Systems in Cutaneous Squamous Cell Carcinoma

Impact of HLA Antigen Mismatches on Skin Cancer Risk in Transplant Recipients

Use of Cetuximab in Multimodality Treatment of Cutaneous Squamous Cell Carcinoma

Factors Contributing to Recurrence of Invasive Squamous Cell Carcinoma

How BMI Interacts With Sun Exposure and Risk of Non-Melanoma Skin Cancer

Using Immunohistochemical Panel to Differentiate Basal Cell Carcinoma and Trichoepithelioma

Risk Factors of Aggressive Skin Cancer in Recipients of Solid Organ Transplants

Research Points to Certain Genetic Links to Cutaneous Squamous Cell Carcinoma

Organ Transplantation and Degree of Differentiation of Cutaneous Squamous Cell Carcinoma

Risk of New Skin Neoplasms in Patients With History of Skin Cancer

Merkel Cell Carcinoma: Need for Timely Diagnosis and Treatment

Study Sheds Light on Cellular Origin of Merkel Cell Carcinoma

Are Some Transplant Recipients Exposed to Voriconazole at Risk for Skin Cancer?

Impact of Tumor Board Conferences on Treatment of Skin Cancer

Master Transcription Factors in Progression of Squamous Cell Carcinoma

Mohs Surgery for High-Risk Squamous Cell Carcinoma

Could Gentian Violet Be Used to Treat Cutaneous T-Cell Lymphoma?

Comparing Outcomes of Different Basal Cell Carcinoma Treatments

MAVORIC Results Support FDA Approval of Mogamulizumab in Cutaneous C-Cell Lymphoma

Case Study Highlights Novel Concurrent Therapy for Cutaneous Squamous Cell Carcinoma

Impact of Non‐Melanoma Skin Cancers on Patients’ Quality of Life

Update on Nonsurgical Treatments of Non-Melanoma Skin Cancer

Identifying Sentinel Lymph Nodes in Merkel Cell Cancer With Indocyanine Green

Do Frequent Occurrences of Basal Cell Carcinoma Increase Risk for Other Cancers?

Do UVA Nail Lamps Pose Cutaneous Carcinogenic Risk?

Identifying Renal Transplant Patients at Risk for Squamous Cell Carcinoma by DNA Methylation of T Cells

Depth of Follicular Involvement in Invasive Squamous Cell Carcinoma

Does Renal Transplant Rejection Influence Risk of Developing Squamous Cell Carcinoma?

Delayed Skin Reactions Reported With PD-1 Inhibitors

Comparison of Photodynamic Therapies for Active Keratosis

New Guidelines for Treating Metastatic Merkel Cell Carcinoma: Focus on Immunotherapy

Squamous Cell Carcinoma of the Lip: Is There a Difference Between Vermilion vs Cutaneous Involvement?

First-Line Avelumab for Metastatic Merkel Cell Carcinoma

Is There a Link Between Skin Cancers and Alzheimer’s Disease?

AAD Guidelines for Non-Melanoma Skin Cancers

Workplace UV Exposure = Quantifiable Economic Costs

Melanoma Mortality Risk and Nonmelanoma Cancer History: Is There a Connection?